EIN 31-1405490

Parent Project Muscular Dystrophy (PPMD)

IRS 501(c) type
501(c)(3)
Num. employees
26
Year formed
1997
Most recent tax filings
2023-12-01
Description
Parent Project Muscular Dystrophy’s mission is to end Duchenne. We accelerate research, raise our voices in Washington, demand optimal care for all young men, and educate the global community.
Also known as...
The Parent Project for Muscular Dystrophy Research
Total revenues
$13,881,085
2023
Total expenses
$12,112,486
2023
Total assets
$10,440,900
2023
Num. employees
26
2023

Program areas at PPMD

Researchppmd's Research program identifies and aggressively funds The most promising near and long-term duchenne Research across numerous therapeutic strategies; stimulates new Research to ensure that The therapeutic pipeline is rich with opportunity; facilitates pre-competitive industry interactions through The duchenne drug development roundtable to enhance and harmonize The clinical trial landscape; and supports multi-stakeholder data modeling consortia to accelerate drug development timelines. In addition to significant pre-clinical and academic Research funding, through The venture pathways program, ppmd makes investments in early-stage biopharmaceutical companies to catalyze development of novel therapies to treat duchenne and becker. The duchenne registrythe duchenne registry is a patient-reported registry for individuals with duchenne and becker Muscular Dystrophy and carrier females, established by ppmd in 2007, The registry was created to bridge The information gap between clinicians, researchers, and The patient community, thereby addressing medical care needs and accelerating The pace of therapeutic advancements. Over 5,000 families across The globe have embraced their role as citizen scientists and have contributed to The largest patient-reported data set for duchenne.since its launch, data has been referenced in thirteen publications and exported by researchers 65 times. The registry has also been used to identify and connect people with duchenne to over 80 actively recruiting trials. The duchenne outcomes Research interchange (The interchange): The interchange collects patient data and clinician entered data so both sets are so both aggregated and analyzed in one place and key industry stakeholders can get a full picture of how different people live with duchenne. The electronic health record (ehr) study: The ehr study extracts data from several of ppmd's certified duchenne care centers across The country to improve care and answer Research questions in a way that does not require extra effort from patients or their doctor.the registry is also home to ppmd's electronic health record (ehr) extraction study which receives core clinical data elements from some care centers. Careppmd's care program strives to ensure that people living with duchenne are living longer, stronger lives, by helping provide access to expert healthcare providers, a comprehensive team of sub-specialists, and approved treatments. Ppmd identifies gaps in care for people with duchenne throughout The lifespan and collaborates with health care professionals across The globe to improve health outcomes for all duchenne patients. Ppmd's certified duchenne care center program (cdcc) helps to ensure that centers comply with The standards of care and services that have been established in The duchenne care guidelines. All certified duchenne care centers have met The requirements for, and agree to provide, standardized care and services.
Advocacyppmd's advocacy efforts are focused on advancing care and treatments for duchenne by leveraging federal resources, building partnerships, and advancing regulatory procedures and infrastructure. We empower advocates with The tools and information to engage with congressional representatives to foster duchenne champions within congress and to support legislation and regulatory policies, ensuring that duchenne priorities are reflected across all government agencies.ppmd also leads efforts for federal and local legislation to support newborn screening for duchenne.
Educationppmd's education initiatives increase awareness and understanding of The disease progression and The components of multidisciplinary comprehensive care necessary to optimize quality and quantity of life throughout The lifespan. Ppmd partners with experts in duchenne to develop up-to-date informational resources regarding treatment and care that we then share broadly. Ppmd collaborates with national and international organizations to develop and disseminate educational resources appropriate for The global duchenne community.engagement ppmd brings people together for support and learning opportunities at all times. Ppmd hosts The largest global duchenne conference every summer, bringing together patients, families, clinicians, researchers, and industry partners from across The globe to share The latest news and updates. Ppmd also convenes members of The duchenne community through different group gatherings - virtually and in person at various points throughout The year. Current groups include duchenne carriers, duchenne siblings, duchenne dads, duchenne grandparents and newly diagnosed groups. Ppmd also offers 1:1 connection based on specific needs through ppmd together - virtual resource meetings.

Grants made by PPMD

GranteeGrant descriptionAmount
Cincinnati Children's Hospital Medical Center (CCHMC)Research - Action Network Grant, Research- Sibling Case Reports, Care Program- Award for Maintaining PPMD Certified Duchenne Care Center Standards.$588,811
Regents Univ of CaliforniaResearch- DMD Molecular and Cellular Dynamics at Single Nuclei Resolution & Wellstone Supplement$310,000
The University of Florida FoundationResearch- Preclinical Therapeutic Assessment Lab and Uf Biorepository Support- Lilly, NCH, Catabasis Samples Storage$305,346
...and 15 more grants made

Who funds Parent Project Muscular Dystrophy (PPMD)

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Schwab Charitable FundHuman Services$1,090,000
Raymond James Charitable Endowment FundGeneral Support$988,000
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$188,460
...and 40 more grants received totalling $2,853,070

Personnel at PPMD

NameTitleCompensation
Pat FurlongPresident and Chief Executive Officer
Ryan FischerChief Advocacy Officer$187,206
Kaylan MoitosoChief Business Officer$256,267
Jodi WolffChief Program Officer
Ann MartinVice President , Community Research and Genetic Services$172,800
...and 17 more key personnel

Financials for PPMD

RevenuesFYE 12/2023
Total grants, contributions, etc.$12,660,929
Program services$1,210,969
Investment income and dividends$88,182
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$387
Net income from fundraising events$-130,547
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$51,165
Total revenues$13,881,085

Form 990s for PPMD

Fiscal year endingDate received by IRSFormPDF link
2023-122024-07-24990View PDF
2022-122023-08-07990View PDF
2021-122022-11-08990View PDF
2020-122021-11-15990View PDF
2019-122020-12-16990View PDF
...and 9 more Form 990s
Data update history
November 26, 2024
Received grants
Identified 13 new grant, including a grant for $101,000 from American Endowment Foundation
October 21, 2024
Updated personnel
Identified 4 new personnel
October 18, 2024
Updated personnel
Identified 2 new personnel
August 29, 2024
Posted financials
Added Form 990 for fiscal year 2023
August 28, 2024
Updated personnel
Identified 5 new personnel
Nonprofit Types
Grantmaking organizationsDisease research fundraisersDisease-focused nonprofitsCharities
Issues
HealthHuman servicesDiseases and disorders
Characteristics
Political advocacyConducts researchLobbyingFundraising eventsOperates internationallyNational levelCommunity engagement / volunteeringTax deductible donationsAccepts online donations
General information
Address
1012 14th St NW 500
Washington, DC 20005
Metro area
Washington-Arlington-Alexandria, DC-VA-MD-WV
County
District of Columbia, DC
Website URL
parentprojectmd.org/ 
Phone
(201) 250-8440
Facebook page
parentprojectmd 
Twitter profile
@parentprojectmd 
IRS details
EIN
31-1405490
Fiscal year end
December
Taxreturn type
Form 990
Year formed
1997
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
G20: Birth Defects and Genetic Diseases
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
California AB-488 details
AB 488 status
May Operate or Solicit for Charitable Purposes
Charity Registration status
Current
FTB status revoked
Not revoked
AG Registration Number
108146
FTB Entity ID
1952135
AB 488 data last updated ("as-of") date
2024-12-31
Free account sign-up

Want updates when PPMD has new information, or want to find more organizations like Parent Project Muscular Dystrophy (PPMD)?

Create free Cause IQ account